Literature DB >> 9329587

Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.

O Micke1, U Schäfer, B Wörmann, W Hiddemann, N Willich.   

Abstract

In this study we investigated whether circadian rhythms of interleukin-2 receptors (sIL-2R), serum thymidine kinase (sTK) and beta-2-microglobulin (beta 2M) are apparent, which may influence tumor marker detection. Blood was drawn every two hours over 24 hours from 6 patients with NHL, 3 healthy donors and three patients with non-hematologic disorders. The serum levels of the three markers were measured. The three normal volunteers showed circadian variations of sIL-2R, sTK and beta 2M best described by a sinusoidal curve. This rhythm could also be demonstrated in three of the six patients with NHL for all three markers. In three patients the circadian rhythm of one marker was disturbed. The three NHL-patients with consistent circadian rhythms in all three markers achieved a complete remission, whereas the patients with disturbed rhythm progressed under therapy. We showed that circadian variations of sIL-2R, sTK and beta 2M follow a sinusoidal circadian rhythm in normals and patients with NHL. Disturbance of this rhythm may be related to a worse prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329587

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma.

Authors:  Nils H Thoennissen; Gabriela B Thoennissen; Sam Abbassi; Shayan Nabavi-Nouis; Tim Sauer; Ngan B Doan; Sigal Gery; Carsten Müller-Tidow; Jonathan W Said; H Phillip Koeffler
Journal:  Leuk Lymphoma       Date:  2012-02-21

2.  Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.

Authors:  Yong Zhu; Derek Leaderer; Carly Guss; Heather N Brown; Yawei Zhang; Peter Boyle; Richard G Stevens; Aaron Hoffman; Qin Qin; Xuesong Han; Tongzhang Zheng
Journal:  Int J Cancer       Date:  2007-01-15       Impact factor: 7.396

3.  Clock-cancer connection in non-Hodgkin's lymphoma.

Authors:  Yong Zhu; Tongzhang Zheng
Journal:  Med Hypotheses       Date:  2007-11-01       Impact factor: 1.538

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.